Boston Scientific cuts full-year targets after cyberattack order disruption
Boston Scientific said it is unlikely to meet full-year sales growth and earnings expectations, citing a major cyberattack disclosed last month that left it unable to fill orders. Shares fell more than 4% Tuesday morning.
By Alex JaninMedical-device maker Boston Scientific said that it is unlikely to meet its sales growth and earnings expectations for the year, citing a major cyberattack disclosed last month that left it unable to fill orders. Boston Scientific's shares fell more than 4% Tuesday morning and are now…